Home › High Blood Pressure › Texas › Arlington
High Blood Pressure clinical trials in Arlington, TX
4 studies for High Blood Pressure are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Arlington
- Clinical Trial Site, Euless · 7 mi away
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
RecruitingPhase 3
- Research Site, Arlington
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RecruitingPhase 3
- Cedar Health Research - Euless, Euless · 7 mi away
Reducing Cardiovascular Risks: The Role of Alcohol Use
Recruiting
- Science and Engineering Innovation and Research Building (SEIR), University of Texas at Arlington, Arlington
About High Blood Pressure
High blood pressure (hypertension) develops when blood flows through arteries at higher than normal pressures. It increases the risk for heart disease and stroke.
More about High Blood Pressure on MedlinePlus
High Blood Pressure trials in other cities
- Chicago, IL21 studies
- Boston, MA21 studies
- Dallas, TX15 studies
- Nashville, TN14 studies
- Birmingham, AL12 studies
- Houston, TX11 studies
- Atlanta, GA10 studies
- Durham, NC10 studies
- Tucson, AZ10 studies
- Rochester, MN9 studies
- Philadelphia, PA9 studies
- Miami, FL9 studies
Other studies in Arlington
- Steatotic Liver Disease7 studies
- Non-Small Cell Lung Cancer4 studies
- Non-Muscle Invasive Bladder Cancer4 studies
- Chronic Kidney Disease4 studies
- Rheumatoid Arthritis4 studies
- Sjögren's Disease4 studies
- Lupus3 studies
- Breast Cancer3 studies
- Ulcerative Colitis3 studies
- Bladder Cancer3 studies
- Cirrhosis3 studies
- Pneumococcal Infections3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.